India to Philippines: Cisplatin Export Trade Route

The India to Philippines Cisplatin corridor is one of India's established pharmaceutical export routes, with 41 shipments documented worth a combined $302.8K USD. The route is dominated by NAPROD LIFE SCIENCES PRIVATE LIMITED, which alone accounts for roughly 25% of all export value, reflecting the consolidated nature of India's cisplatin manufacturing sector.

Across 11 active suppliers, the average shipment value stands at $7.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 81% of all shipments, consistent with cisplatin's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 33 days port-to-port. The route has recorded an annual growth rate of 26.4%, placing it at rank #12 among India's top cisplatin export destinations globally.

On the import side, key buyers of Indian cisplatin in Philippines include MULTICARE PHARMACEUTICALS PHILIPPIN, ASIA UNITED BANK CORPORATION, AGB PHARMACEUTICAL TRADING AND and 9 others. MULTICARE PHARMACEUTICALS PHILIPPIN is the single largest importer with 9 shipments valued at $76.2K USD.

India's cisplatin exports to Philippines are driven primarily by a handful of large-scale manufacturers. NAPROD LIFE SCIENCES PRIVATE LIMITED with 9 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 11 active exporters signals a competitive but concentrated market — buyers in Philippines benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — NAPROD LIFE SCIENCES PRIVATE LIMITED, INTAS PHARMACEUTICALS LIMITED, KHANDELWAL LABORATORIES PRIVATE LIMITED — together account for 58% of total trade value on this route. The average shipment value of $7.4K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as pharm drug&med:platin-cisplatin 1mg/ml,50ml sol for inj)each ml contains: cisplatin bp 1mg water for injections bp q.svls and cisteen cisplatin injection bp 50mg/50ml, suggesting that buyers in Philippines tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, MULTICARE PHARMACEUTICALS PHILIPPIN is the largest importer with 9 shipments worth $76.2K USD — representing 25% of all cisplatin imports from India on this route. A total of 12 buyers are active on this corridor.